nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

04.11.2016 | Original Article

Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus

verfasst von: H. Ghasemzadeh-Moghaddam, W. van Wamel, A. van Belkum, R. A. Hamat, V. K. Neela

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

The humoral immune response against 43 staphylococcal antigens was compared among hospitalized patients where none of them had any staphylococcal infection on the day of admission with or without nasal Staphylococcus aureus carriage. Fifty-nine carriers and 59 matched non-carriers were studied. The carriers harbored S. aureus of 35 different spa types, including three t037/ST239 methicillin-resistant S. aureus (MRSA) (5.1%). Among the 118 patients, 31 acquired S. aureus during hospitalization. In colonized and non-colonized patients, unique patterns of S. aureus-specific immune responses were observed. The mean fluorescence indices (MFIs) of antibodies against 36/43 (83.7%) antigens were seen to be elevated among carriers. The MFI among carriers with acquisition was significantly higher for staphylococcal superantigen-like protein 5 (SSL5, p = 0.028) when compared to carriers without acquisition. High antibody levels against staphylococcal enterotoxin A (SEA) among carriers illustrate its role as a superantigen in both infection and colonization. We also report a dynamic immune response in S. aureus-carrying patients against the recently reported formyl peptide receptor-like inhibitory (FLIPr)-like protein. In the current study, the dynamics of antibodies against staphylococcal antigens among carrier patients seem quite similar to non-carrier patients. To better understand the dynamic immunogenicity during S. aureus infection and colonization, artificial colonization studies and investigation of the changes in the levels of antibodies against other staphylococcal antigens are recommended.

Nur mit Berechtigung zugänglich

Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ (1999) The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 20(11):725–730CrossRefPubMed

van der Mee-Marquet N, Domelier AS, Girard N, Quentin R; Bloodstream Infection Study Group of the Relais d’Hygiène du Centre (2004) Epidemiology and typing of Staphylococcus aureus strains isolated from bloodstream infections. J Clin Microbiol 42(12):5650–5657CrossRefPubMedPubMedCentral

De Lencastre H, Oliveira D, Tomasz A (2007) Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol 10(5):428–435CrossRefPubMedPubMedCentral

Bode LGM, Kluytmans JAJW, Wertheim HFL, Bogaers D, Vandenbroucke-Grauls CMJE, Roosendaal R, Troelstra A, Box ATA, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC (2010) Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362(1):9–17CrossRefPubMed

von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344(1):11–16CrossRef

Wertheim HFL, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JAJW, van Keulen PHJ, Vandenbroucke-Grauls CMJE, Meester MHM, Verbrugh HA (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364(9435):703–705CrossRefPubMed

Peacock SJ, Justice A, Griffiths D, de Silva GDI, Kantzanou MN, Crook D, Sleeman K, Day NPJ (2003) Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 41(12):5718–5725CrossRefPubMedPubMedCentral

VasanthaKumari N, Alshrari ASD, Ghaznavi Rad E, Ghasemzadeh Moghaddam H, van Belkum A, Alreshidi MA, Selamat N, Nor Shamsudin M (2009) Highly dynamic transient colonization by Staphylococcus aureus in healthy Malaysian students. J Med Microbiol 58(Pt 11):1531–1532CrossRefPubMed

van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Wertheim HFL (2009) Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 199(12):1820–1826CrossRefPubMed

10.

Holtfreter S, Roschack K, Eichler P, Eske K, Holtfreter B, Kohler C, Engelmann S, Hecker M, Greinacher A, Broker BM (2006) Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis 193(9):1275–1278CrossRefPubMed

11.

Liese JG, Jendrossek V, Jansson A, Petropoulou T, Kloos S, Gahr M, Belohradsky BH (1996) Chronic granulomatous disease in adults. Lancet 347(8996):220–223CrossRefPubMed

12.

Verkaik NJ, Boelens HA, de Vogel CP, Tavakol M, Bode LGM, Verbrugh HA, van Belkum A, van Wamel WJB (2010) Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 29(5):509–518CrossRefPubMedPubMedCentral

13.

Ghasemzadeh-Moghaddam H, Neela V, van Wamel W, Awang Hamat R, Nor Shamsudin M, Che Hussin NS, Aziz MN, Saffari Mohammad Haspani M, Johar A, Thevarajah S, Vos M, van Belkum A (2015) Nasal carriers are more likely to acquire Exogenous Staphylococcus aureus strains than non-carriers. Clin Microbiol Infect 21(11):998.e1–998.e7CrossRef

14.

Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG (1998) Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. J Clin Microbiol 36(3):618–623PubMedPubMedCentral

15.

Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, Bost DA, Riehman M, Naidich S, Kreiswirth BN (1999) Evaluation of protein a gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 37(11):3556–3563PubMedPubMedCentral

16.

Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41(12):5442–5448CrossRefPubMedPubMedCentral

17.

den Reijer PM, Lemmens-den Toom N, Kant S, Snijders SV, Boelens H, Tavakol M, Verkaik NJ, van Belkum A, Verbrugh HA, van Wamel WJB (2013) Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. PLoS One 8(1), e53391CrossRef

18.

Martins TB, Augustine NH, Hill HR (2006) Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group a streptococci. J Immunol Methods 316(1–2):97–106CrossRefPubMed

19.

Verkaik N, Brouwer E, Hooijkaas H, van Belkum A, van Wamel W (2008) Comparison of carboxylated and penta-His microspheres for semi-quantitative measurement of antibody responses to His-tagged proteins. J Immunol Methods 335(1–2):121–125CrossRefPubMed

20.

Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, Kustos T, Henics T, Meinke A, Nagy E (2005) Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol 12(3):387–398PubMedPubMedCentral

21.

Jacobsson G, Colque-Navarro P, Gustafsson E, Andersson R, Möllby R (2010) Antibody responses in patients with invasive Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis 29(6):715–725CrossRefPubMed

22.

Verkaik NJ, de Vogel CP, Boelens HA, Grumann D, Hoogenboezem T, Vink C, Hooijkaas H, Foster TJ, Verbrugh HA, van Belkum A, van Wamel WJ (2009) Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis 199(5):625–632CrossRefPubMed

23.

Al-Shangiti AM, Naylor CE, Nair SP, Briggs DC, Henderson B, Chain BM (2004) Structural relationships and cellular tropism of staphylococcal superantigen-like proteins. Infect Immun 72(7):4261–4270CrossRefPubMedPubMedCentral

24.

Fitzgerald JR, Reid SD, Ruotsalainen E, Tripp TJ, Liu M, Cole R, Kuusela P, Schlievert PM, Järvinen A, Musser JM (2003) Genome diversification in Staphylococcus aureus: molecular evolution of a highly variable chromosomal region encoding the staphylococcal exotoxin-like family of proteins. Infect Immun 71(5):2827–2838CrossRefPubMedPubMedCentral

25.

Bestebroer J, van Kessel KPM, Azouagh H, Walenkamp AM, Boer IGJ, Romijn RA, van Strijp JAG, de Haas CJC (2009) Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. Blood 113(2):328–337CrossRefPubMed

26.

De Haas CJC, Weeterings C, Vughs MM, De Groot PG, Van Strijp JA, Lisman T (2009) Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibα and αIIbβ3. J Thromb Haemost 7(11):1867–1874CrossRefPubMed

27.

Itoh S, Hamada E, Kamoshida G, Takeshita K, Oku T, Tsuji T (2010) Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils. Infect Immun 78(7):3298–3305CrossRefPubMedPubMedCentral

28.

Williams RJ, Ward JM, Henderson B, Poole S, O’Hara BP, Wilson M, Nair SP (2000) Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun 68(8):4407–4415CrossRefPubMedPubMedCentral

29.

Prat C, Haas P-J, Bestebroer J, de Haas CJC, van Strijp JAG, van Kessel KPM (2009) A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. J Immunol 183(10):6569–6578CrossRefPubMed

30.

Stemerding AM, Köhl J, Pandey MK, Kuipers A, Leusen JH, Boross P, Nederend M, Vidarsson G, Weersink AYL, van de Winkel JGJ, van Kessel KPM, van Strijp JAG (2013) Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions. J Immunol 191(1):353–362CrossRefPubMed

31.

Ferry T, Thomas D, Genestier A-L, Bes M, Lina G, Vandenesch F, Etienne J (2005) Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis 41(6):771–777CrossRefPubMed

32.

Jarraud S, Peyrat MA, Lim A, Tristan A, Bes M, Mougel C, Etienne J, Vandenesch F, Bonneville M, Lina G (2001) egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol 166(1):669–677CrossRefPubMed

33.

Ferry T, Perpoint T, Vandenesch F, Etienne J (2005) Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes. Curr Infect Dis Rep 7:420–428CrossRefPubMed

34.

Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C (2003) Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol 41(4):1434–1439CrossRefPubMedPubMedCentral

35.

Cho JW, Cho S-Y, Lee KS (2009) Roles of SEA-expressing Staphylococcus aureus, isolated from an atopic dermatitis patient, on expressions of human beta-defensin-2 and inflammatory cytokines in HaCaT cells. Int J Mol Med 23:331–335PubMed

36.

Kérouanton A, Hennekinne JA, Letertre C, Petit L, Chesneau O, Brisabois A, De Buyser ML (2007) Characterization of Staphylococcus aureus strains associated with food poisoning outbreaks in France. Int J Food Microbiol 115(3):369–375CrossRefPubMed

37.

Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, O’Neill G, Day NPJ (2002) Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun 70(9):4987–4996CrossRefPubMedPubMedCentral

38.

van Wamel WJB, Rooijakkers SHM, Ruyken M, van Kessel KPM, van Strijp JAG (2006) The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol 188(4):1310–1315CrossRefPubMedPubMedCentral

39.

Tremaine MT, Brockman DK, Betley MJ (1993) Staphylococcal enterotoxin A gene (sea) expression is not affected by the accessory gene regulator (agr). Infect Immun 61(1):356–359PubMedPubMedCentral

40.

Kusch K, Hanke K, Holtfreter S, Schmudde M, Kohler C, Erck C, Wehland J, Hecker M, Ohlsen K, Bröker B, Engelmann S (2011) The influence of SaeRS and σ^B on the expression of superantigens in different Staphylococcus aureus isolates. Int J Med Microbiol 301(6):488–499CrossRefPubMed

41.

Dauwalder O, Thomas D, Ferry T, Debard A-L, Badiou C, Vandenesch F, Etienne J, Lina G, Monneret G (2006) Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leukoc Biol 80(4):753–758CrossRefPubMed

42.

Holtfreter S, Bauer K, Thomas D, Feig C, Lorenz V, Roschack K, Friebe E, Selleng K, Lövenich S, Greve T, Greinacher A, Panzig B, Engelmann S, Lina G, Bröker BM (2004) egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect Immun 72(7):4061–4071CrossRefPubMedPubMedCentral

43.

Colque-Navarro P, Jacobsson G, Andersson R, Flock J-I, Möllby R (2010) Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin Vaccine Immunol 17(7):1117–1123CrossRefPubMedPubMedCentral

44.

Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, Badiou C, Bes M, Vandenesch F, Tazir M, Hooijkaas H, Verbrugh HA, van Belkum A, Etienne J, Lina G, Ramdani-Bouguessa N, van Wamel WJ (2009) Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis 50(1):61–68CrossRef

45.

Nilsson IM, Verdrengh M, Ulrich RG, Bavari S, Tarkowski A (1999) Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis 180(4):1370–1373CrossRefPubMed

Titel: Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus
verfasst von: H. Ghasemzadeh-Moghaddam
W. van Wamel
A. van Belkum
R. A. Hamat
V. K. Neela
Publikationsdatum: 04.11.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 3/2017
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-016-2817-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial

High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied

MALDI-TOF MS meets WGS in a VRE outbreak investigation

Influenza virus infections in patients with malignancies –– characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO)

Proteomics progresses in microbial physiology and clinical antimicrobial therapy

Paediatric antibiotic prescriptions in primary care in the Alpes-Maritimes area of southeastern France between 2008 and 2013

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin